Firdapse, Tabletten

7680618530019 CH-61853 Tabletten

Associated product:

FIRDAPSE cpr 10 mg 100 pce
Firdapse, Tabletten
Firdapse, Tabletten
Firdapse, Tabletten
1 / 3
google

Article details

Package size
100
Selling units
100
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
30/05/2022
Summary of Product Characteristics
Français
30/05/2022
Summary of Product Characteristics
Italien
30/05/2022
Patient information leaflet
Allemand
16/05/2022
Patient information leaflet
Français
16/05/2022
Patient information leaflet
Italien
16/05/2022

Detailed composition

Substance Quantity Type Category
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 1567.25
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/09/2025

Authorization holder

DRAC AG

3280 Murten

Authorization information

Swissmedic authorization number
61853
Drug name
Firdapse, Tabletten
Galenic form
TAB
ATC Code
N07XX05
Authorization status
Z
Dispensing category
B
First authorization
22/08/2012
Authorization expiration date
31/12/9999
IT Number
01.14.0.
Domain
Human medicine
Field of application
Symptomatische Behandlung des Lambert-Eaton-Myasthenie Syndroms (LEMS) bei Erwachsenen

Package details

Description (FR)
FIRDAPSE cpr 10 mg 100 pce
Description (DE)
FIRDAPSE Tabl 10 mg 100 Stk
Market launch
22/08/2012
Narcotic (BTM)
No